Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colonization Kinetics of LC106 in Bacterial Vaginosis
NCT07305844Phase 1Completed
- Start
- Apr 2026
- Primary completion
- Aug 2026
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of LC106 in bacterial vaginosis (BV). Primary endpoint: Rate of colonization with LBP isolates at 5 weeks. Started Apr 2026; status: completed.
02
Drugs
LC106
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07305844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07305844.